MedPath
NMPA Approval

Sulfogaiacol,Pentoxyverine and Promethazine Granules

国药准字H35021207

September 16, 2020

Drug Information

愈酚喷托异丙嗪颗粒

郎尔安

颗粒剂

复方

化学药品

September 16, 2020

Company Information

Applicant Company

Manufacturing Company

福建省泉州经济技术开发区吉泰路288号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

愈酚喷托异丙嗪颗粒 - NMPA 批准文号 | MedPath